Therma Bright's Investment Partnership InStatin Joins Forces with InVixa to Enhance Its Patent Portfolio For The Development Of Innovative Respiratory Solutions
Toronto, Ontario--(Newsfile Corp. - October 28, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF), a leading developer and investment partner in advanced diagnostic and medical device technologies, is pleased to announce a significant development with its investment partners, InStatin and InVixa. InVixa will assign its licensing agreement to InStatin, contingent upon approval from the University of California, Davis.The collaboration marks a pivotal step in the integration of these two businesses. This strategic move of InVixa assigning InStatin with...
2024-10-28 7:00 AM EDT
Therma Bright Announces Shares for Debt Issuance
Toronto, Ontario--(Newsfile Corp. - October 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, announces further to its press release of September 18, 2024, it has now issued an aggregate of 5,056,250 common shares at a deemed price of $0.08 per share to settle aggregate debt of $404,500.All shares issued in relation to these debt...
2024-10-18 5:00 PM EDT
Therma Bright Announces Quantify Medical as Nationwide U.S. Distribution Partner from August 22, 2024 Press Release
Therma Bright Closes First Tranche of Non-Brokered Concurrent Private Placement for CAD $174,900Toronto, Ontario--(Newsfile Corp. - October 10, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce that its nationwide U.S. medical device distribution partner as Quantify Medical as previously announced on August 22, 2024. Quantify Medical has witnessed promising preliminary success with...
2024-10-10 6:30 AM EDT
Therma Bright Announces Non-Brokered LIFE Financing & Concurrent Private Placement for up to a combined CAD$6 Million
Toronto, Ontario--(Newsfile Corp. - September 27, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce that it will be conducting a non-brokered listed issuer financing exemption (LIFE) private placement of up to CAD$3,000,000 through the issuance of up to 50,000,000 common shares of the Company at a price of CAD$0.06 per share (the "LIFE...
2024-09-27 6:00 AM EDT
Therma Bright Investment Portfolio Company InStatin Secures Mountain West Research Discovery Study Agreement
Toronto, Ontario--(Newsfile Corp. - September 23, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in cutting-edge diagnostic and medical device technologies, extends its congratulations to strategic investment portfolio company InStatin on its recent agreement with Mountain West Research to conduct a comprehensive non-GLP discovery study. The pivotal study will explore the pharmacokinetics of the InStatin innovative statin inhalant solution's active pharmaceutical ingredient (API) in both lung and systemic...
2024-09-23 6:00 AM EDT
Therma Bright Announces Shares for Debt Issuance to Include Portfolio Company AI4LYF & IR Agreement
Toronto, Ontario--(Newsfile Corp. - September 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, announces that AI4LYF has agreed to participate in a shares for debt transaction which progresses the Company's contractual obligation to AI4LYF while preserving cash.Therma Bright is the global exclusive license holder of the innovative AI-powered Digital Cough Technology (DCT) which was created by...
2024-09-18 6:00 AM EDT
Therma Bright Welcomes Medical Device & Pharmaceutical Veteran Douglas S. Sommerville to Its Advisory Board
Toronto, Ontario--(Newsfile Corp. - September 12, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in advanced diagnostic and medical device technologies, is pleased to announce the addition of Douglas S. Sommerville to its Advisory Board. With 30 years of experience in sales and operations within the medical device industry, Mr. Sommerville brings a wealth of expertise to the Company.Mr. Sommerville previously served as the Head of Country for Teva Canada...
2024-09-12 6:00 AM EDT
Therma Bright Congratulates John Patton, PhD of InStatin on Receiving the Prestigious Charles G. Thiel Award
Toronto, Ontario--(Newsfile Corp. - September 4, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in cutting-edge diagnostic and medical device technologies, extends its congratulations to strategic investment partner InStatin's John Patton, Ph.D on receiving the prestigious Charles G. Thiel Award for outstanding research and discovery in respiratory drug delivery (RDD).John Patton, Ph.D, a renowned biotechnology scientist, Chairman of InStatin and Head of the Scientific Advisory Board (SAB) for global leader...
2024-09-04 6:00 AM EDT
Therma Bright Major Milestone: Portfolio Company Inretio's Preva(R) Device Achieves 3rd Human Trial Success
Game-Changing Innovation Poised to Transform Stroke and Blood Clot TreatmentTherma Bright's Strategic Investment Helps Medical Device Company Demonstrate Efficacy and Safety in Transforming Ischemic Stroke CareToronto, Ontario--(Newsfile Corp. - August 27, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is thrilled to announce a groundbreaking achievement by its investment portfolio company, Inretio. Inretio's Preva® ischemic...
2024-08-27 6:00 AM EDT
RETRANSMISSION: Therma Bright Secures Nationwide U.S. Distribution Partner For Venowave
Nationwide partner launches initial Venowave sales program to gauge Medicare/Medicaid reimbursement timelines and billing procedures Post initial program success, distributor commits to acquire remaining inventory that totals up to USD $2.38M in reimbursement valueToronto, Ontario--(Newsfile Corp. - August 23, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is proud to announce the addition of a...
2024-08-23 9:18 AM EDT
Therma Bright Secures Nationwide U.S. Distribution Partner For Venowave
Nationwide partner launches initial Venowave sales program to gauge Medicare/Medicaid reimbursement timelines and billing procedures Post initial program success, distributor commits to acquire remaining inventory that totals up to USD $2.38M in reimbursement valueToronto, Ontario--(Newsfile Corp. - August 22, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is proud to announce the addition of a...
2024-08-22 6:00 AM EDT
Venowave VW5 von Therma Bright sichert sich den permanenten HCPCS Code E0683 der Centers for Medicare & Medicaid Services des U.S.-amerikanischen Gesundheitsministeriums
Das Unternehmen wird voraussichtlich in der kommenden Woche ein Update zum Vertrieb in den USA gebenToronto, Ontario--(Newsfile Corp. - Dienstag, 20. August 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" oder das "Unternehmen"), ein Entwickler und Investitionspartner für eine breite Palette führender, proprietärer Diagnostik- und Medizingerätetechnologien, freut sich bekannt zu geben, dass sein Venowave VW5 am 16. August 2024 von den Centers for Medicare and Medicaid Services (CMS) des U.S.-amerikanischen Gesundheitsministeriums einen permanenten Code unter dem...
2024-08-20 3:33 PM EDT
Therma Bright's Venowave VW5 Secures Permanent HCPCS Code E0683 from U.S. DHHS's Centers for Medicare & Medicaid Services
Company looks to provide a U.S. sales update in the coming weekToronto, Ontario--(Newsfile Corp. - August 19, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce that it's Venowave VW5 has received the permanent Healthcare Common Procedure Coding System (HCPCS) code from the U.S. Department of Health & Human Services' Centers for...
2024-08-19 9:20 AM EDT
Therma Bright's AI-Powered Digital Cough Technology Being Considered as Partner Technology in New Chronic Cough Drug Clinical Trial
Toronto, Ontario--(Newsfile Corp. - August 16, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce that it's AI-powered Digital Cough Technology (DCT), with development partner AI4LYF, is currently being considered as a partner technology for a new innovative, disruptive chronic cough drug US-based clinical trial."We're pleased to learn from our development partners at AI4LFY that...
2024-08-16 6:00 AM EDT
Therma Bright Welcomes Medical & Pharmaceutical Veteran Michael Raimondo to Its Advisory Board
Toronto, Ontario--(Newsfile Corp. - August 13, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce the Company has added Michael Raimondo, a 30-year veteran in sales and operations within the medical and pharmaceutical industries to its advisory board.With more than three (3) decades of experience, Mr. Raimondo brings to the table extensive leadership experience including...
2024-08-13 6:00 AM EDT
Therma Bright Expands InStatin Investment
Toronto, Ontario--(Newsfile Corp. - August 6, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to provide an update on its InStatin investment. With the recent capital raise, the Company has advanced funds to expand its investment in InStatin, as part of SAFE investment plan ("SAFE investment") initiated by InStatin. InStatin is developing a...
2024-08-06 6:22 AM EDT
Therma Bright Receives Positive Notification from U.S. DHHS's Centers for Medicare & Medicaid (CMS)
Toronto, Ontario--(Newsfile Corp. - August 1, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to provide a quick update from a recent notification from US Department of Health and Huma Services' (DHHS) Centers of Medicare and Medicaid (CMS). CMS has informed the Company of the pending permanent Current Procedural Terminology (CPT®) and Healthcare Common...
2024-08-01 7:13 AM EDT
Therma Bright's Venowave VW5 Secures FDA 510K Approval
Toronto, Ontario--(Newsfile Corp. - July 29, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce that the Company has received the U.S. Food and Drug Administration's (FDA) approval on its 510K application request to correct the Venowave VW5 device's intended use, labeling, and description. This approval addresses the U.S. Centers for Medicare and Medicaid Services...
2024-07-29 7:55 AM EDT
Therma Bright Engages Independent Trading Group as Market Maker
Toronto, Ontario--(Newsfile Corp. - July 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, announces that, subject to regulatory approval, it has engaged the services of Independent Trading Group ("ITG") to provide market-making services in accordance with TSX Venture Exchange TSXV policies, ITG will trade shares of the Company on the TSXV and all other trading...
2024-07-18 10:11 AM EDT
Therma Bright Q2, 2024 Market Update On Business
Toronto, Ontario--(Newsfile Corp. - July 3, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to provide a market update on the state of the business, including:$1,000,000 CAD private placement capital raise,Venowave's pending HCPCS and CPT® codes update,Digital Cough Analyzer, powered by AI4LYF, update,InStatin and Inretio investment updates, andCompany's Strategic Review progress.$1M CAD Private Placement Capital...
2024-07-03 6:30 AM EDT